ALERT – Adverse Late Effects of Cancer Treatment (Record no. 28448)

MARC details
000 -LEADER
fixed length control field 02512nam a22003017a 4500
001 - CONTROL NUMBER
control field 20240827083917.0
003 - CONTROL NUMBER IDENTIFIER
control field 20240827083917.0
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240827084527.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 240827b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 978-3-540-75862-4
International Standard Book Number 978-3-540-75863-1
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0942-5373
International Standard Serial Number 2197-4187 (electronic) 4
040 ## - CATALOGING SOURCE
Transcribing agency ddc
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title English
100 ## - MAIN ENTRY--PERSONAL NAME
Fuller form of name Philip Rubin
245 ## - TITLE STATEMENT
Title ALERT – Adverse Late Effects of Cancer Treatment
Remainder of title Normal Tissue Specific Sites and Systems
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. London :
Name of publisher, distributor, etc. Springer-Verlag Berlin Heidelberg :
Date of publication, distribution, etc. 2014
300 ## - PHYSICAL DESCRIPTION
Extent 710 Page
Extent Includes References
490 ## - SERIES STATEMENT
Series statement Normal Tissue Specific Sites and Systems
Volume/sequential designation Volume 2
520 ## - SUMMARY, ETC.
Summary, etc. The literature on the late effects of cancer treatment is widely scattered in different journals since all major organ systems are affected and management is based on a variety of medical and surgical treatments. The aim of ALERT – Adverse Late Effects of Cancer Treatment is to offer a coherent multidisciplinary approach to the care of cancer survivors. The central paradigm is that cytotoxic multimodal therapy results in a perpetual cascade of events that affects each major organ system differently and is expressed continually over time. Essentially, radiation and chemotherapy are intense biologic modifiers that allow for cancer cure and cancer survivorship but accelerate senescence of normal tissues and increase the incidence of age-related diseases and second malignant tumors. Volume 2 of this two-volume work comprehensively documents potential late effects in all the normal tissue anatomic sites in the human body. The detection, diagnosis, management and prevention of effects are all considered in detail, and prognostic outcomes are discussed. Radiation risk factors and interactions with chemotherapy effects are clearly presented. The text is accompanied by numerous supportive illustrations and tables.
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Medical / Allied Health Services / Imaging Technologies, Medical / Biochemistry, Medical / Clinical Medicine, Medical / Diagnostic Imaging / General, Medical / Oncology / General, Medical / Radiology, Radiotherapy & Nuclear Medicine, Oncology, Radiology, Radiology, Medical, Cancer -- Treatment -- Alternative treatment, Cancer -- Treatment -- Complications, Medical radiology, Medicine, Radiotherapy
700 ## - ADDED ENTRY--PERSONAL NAME
Fuller form of name Louis S. Constine
Fuller form of name Lawrence B. Marks
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="DOI 10.1007/978-3-540-75863-1">DOI 10.1007/978-3-540-75863-1</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type E-BOOKS
Suppress in OPAC
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Total checkouts Barcode Date last seen Price effective from Koha item type
          MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO 08/27/2024   20240827083917.0 08/27/2024 08/27/2024 E-BOOKS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024